Ignite Creation Date:
2024-05-06 @ 7:44 PM
Last Modification Date:
2024-10-26 @ 3:12 PM
Study NCT ID:
NCT06116890
Status:
RECRUITING
Last Update Posted:
2024-07-03
First Post:
2023-10-31
Brief Title:
Study to Assess the Efficacy Safety of KHK4951 in Patients With Neovascular Age-Related Macular Degeneration
Sponsor:
Kyowa Kirin Inc
Organization:
Kyowa Kirin Co Ltd
Study Overview
Official Title:
A Phase 2 Multicenter Randomized Double-Masked Parallel Group Study to Assess the Efficacy and Safety of KHK4951 a Vascular Endothelial Growth Factor Receptor Inhibitor in Patients With Neovascular Age-Related Macular Degeneration
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate efficacy and safety of KHK4951 eye drops in patients with nAMD
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None